logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-11. Distribution of clients entering treatment according to age at first use of primary drug and primary drug - EU overall summary in 2005 [see all tables in this series...]

Part (iv) Distribution of all outpatient clients by primary drug for each age group

Substance<1515-1920-2425-2930-3435-3940-4445+Age knownAge not known
Opiates19.536.452.454.052.751.050.130.440.540.4
Cocaine10.520.426.228.830.130.827.220.821.918.4
Stimulants7.710.45.74.02.92.71.51.37.76.7
Hypnotics and sedatives1.82.34.05.36.87.610.824.03.53.7
Hallucinogens2.02.72.41.92.12.33.64.62.51.3
Volatile substances0.80.20.10.00.10.00.10.20.20.1
Cannabis 57.126.88.65.34.65.34.87.623.027.0
Other substances 0.60.70.50.60.60.31.711.20.72.3
Total26534862374098318139901547202206162318945758374

Notes:

 Countries reporting data: BG, CZ, DK, IE, EL, ES, FR, IT, CY, LU, MT, NL, SK, FI, SE 

 Last data available from Spain refer to 2004. 

 The number of treatment clients in each country is listed in [Table TDI-7]. 

 See also 'TDI-107-All outpatient age at first use and primary drug.xls' on distribution by country and 'General notes for interpreting data' on the Explanatory notes and help page

Sources:

 2006 Reitox national reports - Table TDI outpatient treatment centres. 

Page last updated: Monday, 12 November 2007